Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JNLV | ISIN: CA46604F1099 | Ticker-Symbol: 1R3
Stuttgart
06.06.25 | 08:05
0,162 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
IZOTROPIC CORPORATION Chart 1 Jahr
5-Tage-Chart
IZOTROPIC CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
0,1580,18515:47
0,1620,18215:30

Aktuelle News zur IZOTROPIC Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
IZOTROPIC Aktie jetzt für 0€ handeln
20.05.EQS-News: Izotropic Corporation: FDA-Zulassungsverfahren von Izotropic genehmigt - Unternehmen gibt Update537EQS-News: Izotropic Corporation / Schlagwort(e): Miscellaneous FDA-Zulassungsverfahren von Izotropic genehmigt - Unternehmen gibt Update 20.05.2025 / 21:48 CET/CEST Für...
► Artikel lesen
17.05.Izotropic Corp: Izotropic in financing meetings for U.S. clinical study3
17.05.Izotropic Corporation: Izotropic's U.S. FDA Regulatory Pathway Greenlit, Company Provides Corporate Update1.042- Regulatory alignment with FDA confirmed, clearing path to pivotal U.S. clinical trial -- 150-page strategic business plan and advanced financial models completed -- Investor outreach launched to...
► Artikel lesen
03.04.Izotropic Corp: Izotropic hires international communications consultant5
02.04.Izotropic Corporation: Izotropic Engages International Communications Consultant, Grants Incentive Stock Options & RSUs to Key Personnel, Amends Promissory Note with Primary Lender560Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - April 2, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device...
► Artikel lesen
25.03.Izotropic Corp: Izotropic completes presubmission meeting with FDA4
25.03.Izotropic Corporation: Izotropic Completes Pre-Submission Meeting with FDA for Breast Cancer Screening Indication207- FDA meeting facilitated positive collaborative exchange -- Key topics included the clinical study protocol synopsis, the benefits versus risks of contrast-enhancement, and the management of breast...
► Artikel lesen
10.03.Izotropic Corporation: Izotropic to Present at Investor Conference March 13th278- CEO to discuss IzoView's competitive advantage, expansion strategy, and potential revenue models -- Event includes live Q and A, attendance is complimentary -- Individual and institutional investors...
► Artikel lesen
19.02.Izotropic Corp: Izotropic to meet with U.S. FDA on March 2019
19.02.Izotropic Corporation: FDA Sets Meeting Date with Izotropic235Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 19, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device...
► Artikel lesen
14.02.Izotropic Corp: Izotropic closes $455,000 private placement2
14.02.Izotropic Corporation: Izotropic Closes Non-Brokered Private Placement296Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 14, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device...
► Artikel lesen
07.02.Izotropic Corp: Izotropic arranges $360,000 private placement2
07.02.Izotropic Corporation: Izotropic Announces Non-Brokered Private Placement411THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 7, 2025)...
► Artikel lesen
06.02.Izotropic Corp: Izotropic CEO cancels OTC conference over emergency9
06.02.Izotropic Corporation: Izotropic Reschedules Investor Conference Presentation to March 13th612Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 5, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device...
► Artikel lesen
03.02.Izotropic Corporation: Izotropic to Present at Investor Conference February 6th327- CEO to present overview of Company value proposition, unique catalysts, and near-term objectives -- Event includes live Q and A, attendance is complimentary -- Individual and institutional investors...
► Artikel lesen
30.01.Izotropic Corp: Izotropic talks timeline for medical imaging device4
29.01.Izotropic Corporation: Izotropic Announces Timelines and Milestones to IzoView Product Launch297- Unique dense breast tissue focus to drive expedited recruitment rates; modular clinical study design reduces time to PMA submission by ~6 months -- 3 Site U.S.-based clinical study enables early...
► Artikel lesen
17.01.Izotropic Corporation: Izotropic Featured in Announcement of Research and Markets' U.S. Breast Cancer Analysis and Forecast457- Company listed in Research and Markets' announcement and description of new research report on the U.S. Breast Cancer Screening and Diagnostic Market- - "U.S. breast cancer screening and diagnostic...
► Artikel lesen
Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2